Literature DB >> 16415125

An evaluation of methods for the reconstitution of cytochromes P450 and NADPH P450 reductase into lipid vesicles.

James R Reed1, Rusty W Kelley, Wayne L Backes.   

Abstract

Two methods (cholate dialysis and cholate gel filtration) used to incorporate cytochromes P450 (P450s) and reductase into unilamellar phospholipid vesicles were compared with a standard reconstituted system (SRS) in which the proteins were reconstituted with preformed liposomes. Both cholate dialysis and gel filtration methods were comparable in their ability to physically incorporate reductase and either CYP2B4 or CYP1A2 into phospholipid, as determined by the elution of enzymes in the void volume using size exclusion chromatography (mol. wt. cutoff -5,000,000). Incorporation of these proteins was more efficient with both cholate methods than when reductase and P450 were mixed with preformed vesicles (SRS). Using either cholate method, more than 85% of the P450 was physically incorporated into the phospholipid vesicles, whereas less than 40% of the P450 was physically incorporated into the phospholipid vesicles using the SRS. Catalytic activities of the vesicular preparations of reductase and either CYP1A2 or CYP2B4 also were significantly higher than those resulting from the SRS using dilaurylphosphatidylcholine. Although both cholate dialysis and gel filtration methods improved protein incorporation when compared with preincubation of proteins with preformed liposomes, reductase incorporation was dependent on the relative amount of reductase used. Reductase incorporation was complete at a 0.2:1 reductase/P450 ratio; however, the efficiency of incorporation decreased to less than 50% at equimolar reductase/P450. Interestingly, reductase incorporation was higher in the presence of CYP1A2 than with CYP2B4. Both cholate methods resulted in the loss of a proportion of spectrally detectable carbon monoxyferrous P450, resulting from incubation of the proteins with detergent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415125      PMCID: PMC2041853          DOI: 10.1124/dmd.105.006825

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  22 in total

1.  Expression of human cytochrome P450 2B6 in Escherichia coli: characterization of catalytic activity and expression levels in human liver.

Authors:  I H Hanna; J R Reed; F P Guengerich; P F Hollenberg
Journal:  Arch Biochem Biophys       Date:  2000-04-01       Impact factor: 4.013

2.  Effects of ionic strength on the functional interactions between CYP2B4 and CYP1A2.

Authors:  Rusty W Kelley; James R Reed; Wayne L Backes
Journal:  Biochemistry       Date:  2005-02-22       Impact factor: 3.162

3.  Reconstitution of the liver microsomal hydroxylase system into liposomes.

Authors:  M Ingelman-Sundberg; H Glaumann
Journal:  FEBS Lett       Date:  1977       Impact factor: 4.124

4.  Hydroxylation of benzphetamine and other drugs by a solubilized form of cytochrome P-450 from liver microsomes: lipid requirement for drug demethylation.

Authors:  A Y Lu; H W Strobel; M J Coon
Journal:  Biochem Biophys Res Commun       Date:  1969-08-15       Impact factor: 3.575

5.  Biochemical and genetic factors influencing drug metabolism. Influence of hepatic microsomal mixed function oxidation reactions on cellular metabolic control.

Authors:  R W Estabrook; M R Franklin; B Cohen; A Shigamatzu; A G Hildebrandt
Journal:  Metabolism       Date:  1971-02       Impact factor: 8.694

6.  Temperature dependence of cytochrome P-450 reduction. A model for NADPH-cytochrome P-450 reductase:cytochrome P-450 interaction.

Authors:  J A Peterson; R E Ebel; D H O'Keeffe; T Matsubara; R W Estabrook
Journal:  J Biol Chem       Date:  1976-07-10       Impact factor: 5.157

7.  Two forms of liver microsomal cytochrome P-450, P-450lm2 and P-450LM4 (rabbit liver).

Authors:  M J Coon; T A van der Hoeven; S B Dahl; D A Haugen
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

Review 8.  Organization of multiple cytochrome P450s with NADPH-cytochrome P450 reductase in membranes.

Authors:  Wayne L Backes; Rusty W Kelley
Journal:  Pharmacol Ther       Date:  2003-05       Impact factor: 12.310

9.  Theoretical study of the ligand-CYP2B4 complexes: effect of structure on binding free energies and heme spin state.

Authors:  Danni L Harris; Jin-Young Park; Larry Gruenke; Lucy Waskell
Journal:  Proteins       Date:  2004-06-01

Review 10.  The many roles of cytochrome b5.

Authors:  John B Schenkman; Ingela Jansson
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

View more
  13 in total

1.  Physical incorporation of NADPH-cytochrome P450 reductase and cytochrome P450 into phospholipid vesicles using glycocholate and Bio-Beads.

Authors:  James R Reed; Lauren M Brignac-Huber; Wayne L Backes
Journal:  Drug Metab Dispos       Date:  2007-11-29       Impact factor: 3.922

2.  Functional reconstitution of monomeric CYP3A4 with multiple cytochrome P450 reductase molecules in Nanodiscs.

Authors:  Yelena V Grinkova; Ilia G Denisov; Stephen G Sligar
Journal:  Biochem Biophys Res Commun       Date:  2010-06-17       Impact factor: 3.575

Review 3.  Cytochrome P450 Organization and Function Are Modulated by Endoplasmic Reticulum Phospholipid Heterogeneity.

Authors:  Lauren M Brignac-Huber; Ji Won Park; James R Reed; Wayne L Backes
Journal:  Drug Metab Dispos       Date:  2016-05-27       Impact factor: 3.922

4.  Molecular cloning and enzymatic characterization of sheep CYP2J.

Authors:  A Messina; S Nencioni; P G Gervasi; K H Gotlinger; M L Schwartzman; V Longo
Journal:  Xenobiotica       Date:  2010-02       Impact factor: 1.908

Review 5.  Formation of P450 · P450 complexes and their effect on P450 function.

Authors:  James R Reed; Wayne L Backes
Journal:  Pharmacol Ther       Date:  2011-11-29       Impact factor: 12.310

6.  Organization of NADPH-cytochrome P450 reductase and CYP1A2 in the endoplasmic reticulum--microdomain localization affects monooxygenase function.

Authors:  Lauren Brignac-Huber; James R Reed; Wayne L Backes
Journal:  Mol Pharmacol       Date:  2010-12-14       Impact factor: 4.436

Review 7.  The functional effects of physical interactions involving cytochromes P450: putative mechanisms of action and the extent of these effects in biological membranes.

Authors:  James R Reed; Wayne L Backes
Journal:  Drug Metab Rev       Date:  2016-08       Impact factor: 4.518

8.  Relationship between CYP1A2 localization and lipid microdomain formation as a function of lipid composition.

Authors:  Lauren M Brignac-Huber; James R Reed; Marilyn K Eyer; Wayne L Backes
Journal:  Drug Metab Dispos       Date:  2013-08-20       Impact factor: 3.922

9.  C-Terminal membrane spanning region of human heme oxygenase-1 mediates a time-dependent complex formation with cytochrome P450 reductase.

Authors:  Warren J Huber Iii; Brittni A Scruggs; Wayne L Backes
Journal:  Biochemistry       Date:  2009-01-13       Impact factor: 3.162

10.  Functional interactions between cytochromes P450 1A2 and 2B4 require both enzymes to reside in the same phospholipid vesicle: evidence for physical complex formation.

Authors:  James R Reed; Marilyn Eyer; Wayne L Backes
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.